Description
RADIOPHARMACEUTICALS -DEOBLIGATE FY23 PO AND CONTRACT
Base award description: IGF::CT::IGF RADIOPHARMACEUTICALS
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-01+$338,560= $338,560
- Mod P000012019-10-01+$325,535= $664,095
- Mod P000022020-01-17-$58,962= $605,133
- Mod P000032020-10-01+$312,803= $917,936
- Mod P000042021-10-01+$328,740= $1,246,676
- Mod P000052021-11-30+$0= $1,246,676
- Mod P000062022-01-21-$85,302= $1,161,374
- Mod P000072022-09-01-$109,301= $1,052,073
- Mod P000082022-09-30+$281,980= $1,334,053
- Mod P000092023-09-17-$132,848= $1,201,205
- Mod P000102024-02-07-$70,399= $1,130,806
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-01 | +$338,560 | $338,560 | IGF::CT::IGF RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2019-10-01 | +$325,535 | $664,095 | RADIOPHARMACEUTICALS |
| Mod P00002· CLOSE OUT | 2020-01-17 | −$58,962 | $605,133 | RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2020-10-01 | +$312,803 | $917,936 | RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 2. POP: 1 OCT 2020 - 30 SEP 2021 |
| Mod P00004· EXERCISE AN OPTION | 2021-10-01 | +$328,740 | $1,246,676 | RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 3 POP: 10/01/2021 - 09/30/2022 |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-11-30 | +$0 | $1,246,676 | EO14042 - RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 3 POP: 10/01/2021 - 09/30/2022 |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-01-21 | −$85,302 | $1,161,374 | EO14042 - RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 1 - POP: 10/01/2019 - 09/30/2020 |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-09-01 | −$109,301 | $1,052,073 | EO14042 - RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 1 - POP: 10/01/2019 - 09/30/2020 |
| Mod P00008· EXERCISE AN OPTION | 2022-09-30 | +$281,980 | $1,334,053 | RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 4 - POP: 10/01/2022 - 09/30/2023 |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-09-17 | −$132,848 | $1,201,205 | RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 3 - MOD |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-07 | −$70,399 | $1,130,806 | RADIOPHARMACEUTICALS -DEOBLIGATE FY23 PO AND CONTRACT |
Related awards · 9
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CKP6KSWN1T86)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24525P0017 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $83,797 | FY2025 |
| 36C24524P0040 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $183,324 | FY2024 |
| VA24516P0628 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $630,369 | FY2016 |
| VA24515J0631 | 613-MARTINSBURG (00613)(36C613) · 6505 · DRUGS AND BIOLOGICALS | $249,796 | FY2015 |
| VA24514J0989 | 512-BALTIMORE · 6505 · DRUGS AND BIOLOGICALS | $200,672 | FY2014 |
| VA24514J0069 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · W065 · LEASE OR RENTAL OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $113,067 | FY2014 |
Other recipients under Q527 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24524P0903 | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $1,147,040 | FY2024 |
| 36C24521C0180 | THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $972,225 | FY2021 |
| 36C24518C0181 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $793,035 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24519P0045_3600_-NONE-_-NONE- · retrieved 2026-09-26.